The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 18 September 2018 the Company bought 5 000 own shares representing 0.0037% of the share capital of the Company, at a total value of 20 700.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.14 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 165 000, representing 6.80% of the share capital of the Company.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 17 September 2018 the Company bought 1 690 own shares representing 0.0013% of the share capital of the Company, at a total value of 7 013.50 BGN on the Bulgarian Stock Exchange, the average price per share was 4.15 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 160 000, representing 6.80% of the share capital of the Company.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 13 September 2018 the Company bought 4 000 own shares representing 0.003% of the share capital of the Company, at a total value of 16 600.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.15 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 158 310, representing 6.79% of the share capital of the Company.